Does AMACR and Cyclin D1 Immunohistochemical Expression Vary on Comparing Mismatch Repair Proficient Versus Deficient Colorectal Carcinomas?
Dina M. El-Guindy, Eiman A. Hasby, Aliaa Atef, Passant A. El-Sheikh, Mennat-Allah A. Rehab & Rana Khalifa · Journal of Cancer and Tumor International · 2023
Aim of Study: AMACR & Cyclin D1 expression in relation to different clinicopathological features was compared in MMR proficient versus deficient CRC subgroups. Methodology: MLH1 & MSH2 immunostaining was used to sort studied carcinomas. AMACR, cyclin D1 & ki67 express...
Open access
Research Article
10.9734/jcti/2023/v13i2234